Cracking the riddle of cancer anorexia

Nutrition

Volumn 12, Issue 10, 1996, Pages 6-710

  Laviano, Alessandro ^a   Meguid, Michael M ^a   Yang, Zhong Jin ^a   Gleason, John R ^b   Cangiano, Carlo ^c   Fanelli, Filippo Rossi ^c  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b SYRACUSE UNIVERSITY   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

anorexia; cancer; cytokines; human; hypothalamus; rat

Indexed keywords

INTERLEUKIN 1; SEROTONIN; TRYPTOPHAN;

ANOREXIA; ARTICLE; CACHEXIA; CANCER PATIENT; EATING HABIT; HUMAN; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; MALNUTRITION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; TUMOR GROWTH;

EID: 0030272823     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0899-9007(96)00164-5     Document Type: Article

References (54)

1. 1. Grosvenor M, Bulcavage L, Chlebowski RT. Symptoms potentially influencing weight loss in a cancer population. Cancer 1989;63:330
2. 2. Warren S. The immediate causes of death in cancer. Am J Med Sci 1932;184:610
3. 3. Leibowitz SF. The role of serotonin in eating disorders. Drugs 1990;39(suppl 3):33
4. 4. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological dependence on plasma tryptophan levels. Science 1971;173:149
5. 5. Krause R, James JH, Ziparo V, Fischer JE. Brain tryptophan and neoplastic anorexia-cachexia syndrome. Cancer 1979;44:1003
6. 6. Meguid MM, Muscaritoli M, Beverly JL, et al. The early cancer anorexia paradigm: changes in plasma free tryptophan and feeding indexes. JPEN 1992;16(suppl. 6):56S
7. 7. Rossi Fanelli F, Cangiano C, Ceci F, et al. Plasma tryptophan and anorexia in human cancer. Eur J Cancer Clin Oncol 1986;22:89
8. 8. Cangiano C, Cascino A, Ceci F, et al. Plasma and CSF tryptophan in cancer anorexia. J Neural Transm-Gen Sect 1990;81:225
9. 9. Cangiano C, Laviano A, Meguid MM, et al. Effects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patients. J Natl Cancer Inst 1996;88:550
10. 10. Rossi Fanelli F, Cangiano C. Increased availability of tryptophan in brain as a common pathogenic mechanism for anorexia associated with different diseases. Nutrition 1991;7:364
11. 11. Cascino A, Cangiano C, Ceci F, et al. Increased plasma free tryptophan levels in human cancer: a tumor related effect? Anticancer Res 1991;11:1313
12. 12. Curzon G, Joseph MH, Knott PJ. Effects of immobilization and food deprivation on rat brain tryptophan metabolism. J Neurochem 1972;19:1967
13. 13. Schaechter JD, Wurtman RJ. Serotonin release varies with brain tryptophan levels. Brain Res 1990;532:203
14. 14. Gelin J, Moldawer LL, Lonnroth C, et al. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Res 1991;51:415
15. 15. Langstein HN, Norton JA. Mechanisms of cancer cachexia. Hematol Oncol Clin North Am 1991;5:103
16. 16. Tracey KJ, Morgello S, Koplin B, et al. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. J Clin Invest 1990;86:2014
17. 17. Fantino M, Wieteska L. Evidence for a direct central anorectic effect of tumor necrosis factor alpha in the rat. Physiol Behav 1993;53:477
18. 18. Plata Salaman CR, Oomura Y, Kai Y. Tumor necrosis factor and interleukin-1beta: suppression of food intake by direct action in the central nervous system. Brain Res 1988;448:106
19. 19. Gatti S, Bartfai T. Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res 1993;624:291
20. 20. Lechan RM, Toni R, Clark BD, et al. Immunoreactive interleukin-1 beta localization in the rat forebrain. Brain Res 1990;514:135
21. 21. Breder CD, Dinarello CA, Saper CB. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 1988;240:321
22. 22. Farrar WL, Kilian PL, Ruff MR, Hill JM, Pert CB. Visualization and characterization of interleukin-1 receptors in brain. J Immunol 1987;139:459
23. 23. Kuriyama K, Hori T, Mori T, Nakashima T. Actions of interferon alpha and interleukin-1 beta on the glucose-responsive neurons in the ventromedial hypothalamus. Brain Res Bull 1990;24:803
24. 24. Yang Z-J, Koseki M, Meguid MM, Gleason JR, Debonis D. Synergistic effect of rhTNF-alpha and rhIL-1alpha in inducing anorexia in rats. Am J Physiol 1994;267:R1056
25. 25. Opara EI, Laviano A, Meguid MM, Yang Z-J. Correlation between food intake and CSF IL-1alpha in anorectic tumor bearing rats. Neuro Report 1995;6:750
26. 26. Meguid MM, Kawashima Y, Campos AC, et al. Automated computerized rat eater meter: description and application. Physiol Behav 1990;48:759
27. 27. Laviano A, Meguid MM, Renvyle T, et al. IL-1a acts directly on the hypothalamic VMH to mediate cancer anorexia. Surg Forum 1995;46:491
28. 28. Laviano A, Cangiano C, Preziosa I, et al. Serotoninergic block in the ventromedial nucleus of hypothalamus improves food intake in anorectic tumor bearing rats. In: Allegri Filippini G, Costa CVL, eds. Recent advances in tryptophan research. New York: Plenum Press, 1996 (in press)
29. 29. Meguid MM, Yang Z-J, Gleason JR. The gut-brain brain-gut axis in anorexia: toward an understanding of food intake regulation. Nutrition 1996;12(suppl 1):S57
30. 30. Dunn AJ, Welch J. Stress-and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity. J Neurochem 1991;57:1615
31. 31. Dunn AJ. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J Pharmacol Exp Therap 1992;261:964
32. 32. Takao Y, Kamisaki Y, Itoh T. Beta-adrenergic regulation of amine precursor amino acid transport across the blood brain barrier. Eur J Pharmacol 1992;215:245
33. 33. Gemma C, Ghezzi P, De Simoni MG. Activation of the hypothalamic serotoninergic system by central interleukin-1. Eur J Pharmacol 1991;209:139
34. 34. Mohankumar PS, Thyagarajan S, Quadri SK. Interleukin-1beta increases 5-hydroxyindoleacetic acid release in the hypothalamus in vivo. Brain Res Bull 1993;31:745
35. 35. Shintani F, Kanba S, Nakaki T, et al. Interleukin-1beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J Neurosci 1993;13:3574
36. 36. Bartholomew SA, Hoff man SA. Effects of peripheral cytokine injections on multiple unit activity in the anterior hypothalamic area of the mouse. Brain Behav Immun 1993;7:301
37. 37. Plata-Salaman CR, Ffrench-Mullen JMH. Interleukin-1beta depresses calcium currents in CA1 hippocampal neurons at pathophysiological concentrations. Brain Res Bull 1992;29:221
38. 38. Schaechter JD, Wurtman RJ. Tryptophan availability modulates serotonin release from rat hypothalamic slices. J Neurochem 1989;53:1925
39. 39. Banks WA, Ortiz L, Plotkin SR, Kastin AJ. Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Therap 1991;259:988
40. 40. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992;263:C1
41. 41. Saito M, Akiyoshi M, Shimizu Y. Possible role of the sympathetic nervous system in responses to interieukin-1. Brain Res Bull 1993;27:305
42. 42. Plata-Salaman CR. Immunoregulators in the nervous system. Neurosci Biobehav Rev 1991;15:185
43. 43. Cesario TC, Vaziri ND, Ulich TR, et al. Functional, biochemical, and histopathologic consequences of high-dose interleukin-2 administration in rats. J Lab Clin Med 1991;118:81
44. 44. Smith BK, Conn CA, Kluger MJ. Experimental cachexia: effects of MCA sarcoma in the Fischer rat. Am J Physiol 1993;265:R376
45. 45. Chance WT, Balasubramaniam A, Sheriff S, Fischer JE. Possible role of neuropeptide Y in experimental cancer anorexia. Adv Exp MedBiol 1994;354:185
46. 46. Chance WT, van Lammeren F, Chen MH, et al. Plasma and brain cholecystokinin levels in cancer anorexia. J Surg Res 1984;36:490
47. 47. Squadrito F, Calapai G, Cucinotta D, et al. Anorectic activity of N-G-nitro-L-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats. Eur J Pharmacol 1993;230:125
48. 48. Zalcman S, Green-Johnson JM, Murray L, et al. Cytokine-specific central monoamine alterations induced by interieukin-1, -2 and -6. Brain Res 1994;643:40
49. 49. Schlicker E, Gross G, Fink K, Glaser T, Gothert M. Serotonin release in the rat brain cortex is inhibited by neuropeptide Y but not affected by ACTH-24, angiotensin II, bradykinin and delta-sleep-inducing peptide. Naunyn Schmiedeberg's Arch Pharmacol 1991;343:117
50. 50. Dryden S, McCarthy HD, Malabu UH, Ware M, Williams G. Increased neuropeptide Y concentrations in specific hypothalamic nuclei of the rat following treatment with methysergide: evidence that NPY may mediate serotonin's effects on food intake. Peptides 1993;14:791
51. 1C receptors. Am J Physiol 1993;264:R62
52. 52. Squadrito F, Calapai G, Altavilla D, et al. Central serotoninergic system involvement in the anorexia induced by N-G-nitro-L-arginine, an inhibitor of nitric oxide synthase. Eur J Pharmacol 1994;255:51
53. 53. Bandtlow CE, Meyer M, Lindholm D, et al. Regional and cellular codistribution of interieukin-1beta and nerve growth factor mRNA in the adult rat brain: possible relationship to the regulation of nerve growth factor synthesis. J Cell Biol 1991;111:1701
54. 54. Schobitz B, de Kloet ER, Sutanto W, Holsboer F. Cellular localization of interleukin-6 and interleukin-6 receptor mRNA. Eur J Neurosci 1993;1426